![logo](/logos/MTNB.webp)
Matinas BioPharma Holdings, Inc.
AMEX:MTNB
0.2 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Matinas BioPharma Holdings, Inc. |
Symbool | MTNB |
Munteenheid | USD |
Prijs | 0.235 |
Beurswaarde | 50,970,367 |
Dividendpercentage | 0% |
52-weken bereik | 0.11 - 0.89 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jerome D. Jabbour J.D. |
Website | https://www.matinasbiopharma.com |
An error occurred while fetching data.
Over Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)